BeiGene vs Bristol Myers Squibb
BeiGene vs Bristol Myers Squibb, compared side by side on 14 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: BeiGene is on 64/100 and Bristol Myers Squibb on 22/100.
Where each one leads
BeiGene
- our overall score: 64/100 against 22/100
- agent readiness: 50/100 against 44/100
Bristol Myers Squibb
- domain rating: 83/100 against 68/100
At a glance
| Measure | BeiGene | Bristol Myers Squibb |
|---|---|---|
| What it is | A global oncology company developing and commercializing innovative cancer treatments. | A global biopharmaceutical company focused on discovering, developing, and delivering innovative medicines for patients with serious diseases. |
| Category | Biotech, MedTech, HealthTech, Genomics | Biotech, MedTech, HealthTech, Drug Discovery |
| Sells toBusiness model | B2B | B2B |
| Offering | Platform | Services |
| Founded | 2010 | 1989 |
| Headquarters | Cambridge, United States | New York, United States |
| Status | Active | Active |
Size, funding and growth
| Measure | BeiGene | Bristol Myers Squibb |
|---|---|---|
| Employees | Not published | 38,080 |
| Open roles | 100 | Not published |
| Total funding | $358M | Not published |
| Latest round | Secondary Offering | Not published |
| Valuation | $15B | Not published |
| LinkedIn followers | Not published | 1,886,144 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | BeiGene | Bristol Myers Squibb |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 64/100 | 22/100 |
| Traction | 40/100 | 20/100 |
| Team | 30/100 | 10/100 |
| Search visibility | 17/100 | 23/100 |
| Quality | 88/100 | Not published |
| Agent readinessHow well an AI agent can read and act on the site | D (50/100) | D (44/100) |
| Domain ratingLink authority, 0-100 | 68/100 | 83/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | BeiGene | Bristol Myers Squibb |
|---|---|---|
| Hosting | Not detected | Self Managed |
| CDN | Cloudflare | CloudFront |
| CMS | WordPress | Not detected |
| Frameworks | Jquery, Tailwind CSS, Bootstrap | Not detected |
| Analytics | Not detected | Microsoft Clarity, Qualtrics |
What users say
| Measure | BeiGene | Bristol Myers Squibb |
|---|---|---|
| Reddit sentimentThreads we track | Not published | 2 positive, 3 negative across 6 threads |
“Bristol Myers Squibb ist im Kurs gerade günstig und spuckt aktuell über 5% Rendite durch Dividende (vierteljährlich) im Jahr aus. Nichts aufregendes, aber ne solide Bank und nicht vergessen... mühsam ernährt sich das Eichhörnchen.”r/Aktien
BeiGene vs Bristol Myers Squibb: common questions
Which is better, BeiGene or Bristol Myers Squibb?
On our 0-100 score BeiGene rates higher (64/100 against 22/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 14 data points above: read the rows that match what you are buying for.
How do BeiGene and Bristol Myers Squibb compare on the numbers?
BeiGene leads on our overall score (64/100 against 22/100), agent readiness (50/100 against 44/100). Bristol Myers Squibb leads on domain rating (83/100 against 68/100).
What do real users say about BeiGene and Bristol Myers Squibb?
Bristol Myers Squibb: 2 positive and 3 negative mentions across 6 Reddit threads we track, mostly in r/Aktien.
Read the full BeiGene review and pricing or the Bristol Myers Squibb review and pricing. You can also browse other BeiGene alternatives we track.